To our knowledge, the current study provides the most comprehensive investigation regarding the cancer-promoting role of IL-21R by exerting immunosuppressive characteristics of B cells in MASH-driven hepatocarcinogenesis to date, implying that targeting IL-21R signaling represents a potential therapeutic strategy for cancer therapy. Here, IL21R is linked to cancer.